首页 › 基金 › Enavate Sciences GP, LLC › CAMP
Enavate Sciences GP, LLC 对 CAMP 的持仓历史
CAMP4 THERAPEUTICS CORP · 医疗保健
Enavate Sciences GP, LLC 在 Q2 2026 的 13F 申报中披露持有 CAMP(CAMP4 THERAPEUTICS CORP)1,425,541 股,市值约 US$6.2M,约占其申报组合的 1.80%,在其申报持仓中市值排名第 7 位。 Enavate Sciences GP, LLC 最近 7 个申报季度中有 7 个季度披露了 CAMP 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Enavate Sciences GP, LLC 对 CAMP 的持仓演变
Enavate Sciences GP, LLC 于 Q4 2024 首次披露 CAMP 持仓:3,785,802 股(约 US$19.8M)。 在 7 次申报中,Enavate Sciences GP, LLC 0 次增持、3 次减持、3 次保持不变。 最近一期申报(Q2 2026)显示持股 1,425,541 股、市值约 US$6.2M,环比减持 -765,379 股。。 持仓曾出现大幅变动:Q1 2026 减持约 28% (随后一个季度股价基本持平)、Q2 2026 减持约 35% (随后一个季度股价下跌 8%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 3.79M | $19.76M | 新进 |
| Q1 2025 | 3.79M | $15.14M | 持有 |
| Q2 2025 | 3.79M | $5.49M | 持有 |
| Q3 2025 | 3.79M | $11.36M | 持有 |
| Q4 2025 | 3.04M | $18.61M | 减持 |
| Q1 2026 | 2.19M | $9.66M | 减持 |
| Q2 2026 | 1.43M | $6.23M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CAMP 与 13F 数据
CAMP(CAMP4 THERAPEUTICS CORP)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 CAMP,申报仓位最大的包括:5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$18.6M), a16z Capital Management, L.L.C. (US$9.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CAMP 的基金
- 5AM Venture Management, LLC 5.87M 股 · $25.65M · Q2 2026
- Vivo Capital, LLC 4.25M 股 · $18.56M · Q2 2026
- a16z Capital Management, L.L.C. 2.13M 股 · $9.29M · Q2 2026
- Trails Edge Capital Partners, LP 1.93M 股 · $8.45M · Q2 2026
- Stonepine Capital Management, LLC 1.39M 股 · $6.07M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.27M 股 · $5.56M · Q2 2026
更多关于 Enavate Sciences GP, LLC
常见问题
How long has Enavate Sciences GP, LLC held CAMP?
Enavate Sciences GP, LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Enavate Sciences GP, LLC's current position in CAMP?
As of Q2 2026, Enavate Sciences GP, LLC holds 1.43M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $6.23M, representing 1.80% of its reported portfolio and ranking #7.
Has Enavate Sciences GP, LLC been buying or selling CAMP?
In the latest 13F filing (Q2 2026), Enavate Sciences GP, LLC reduced its position in CAMP.
Which other funds hold CAMP?
Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, a16z Capital Management, L.L.C., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.